Logos Capital
Life-science focused investment firm that applies disciplined, data-driven investment in biotechnology and therapeutics. The firm combines clinical and commercial underwriting with a proprietary data science platform (Logos Analytics) to evaluate clinical trial probabilities, track events, and manage risk across private and structured public investments.
Logos Capital
San Francisco, California, United States, North America
Services
Logos Analytics — Predictive clinical-trial modeling
Proprietary data science platform that models clinical trial data, replicates statistical analyses, and refines probabilities of success using predictive simulation, structured parameter testing, and external validation.
Event tracking and clinical trial underwriting
Continuous tracking of clinical milestones, regulatory decisions, and competitive developments paired with underwriting of clinical trial designs to assess intrinsic asset value and anticipate pivotal events.
Strategic collaboration with portfolio management
Engagements with management teams to share tailored analytic insights from Logos Analytics to support strategic planning and decision-making.
Risk management and multi-layered underwriting
Proactive risk management approach that integrates scientific, operational, and commercial factors to evaluate intrinsic value and protect investor returns.
Logos Analytics — Predictive clinical-trial modeling
Proprietary data science platform that models clinical trial data, replicates statistical analyses, and refines probabilities of success using predictive simulation, structured parameter testing, and external validation.
Event tracking and clinical trial underwriting
Continuous tracking of clinical milestones, regulatory decisions, and competitive developments paired with underwriting of clinical trial designs to assess intrinsic asset value and anticipate pivotal events.
Strategic collaboration with portfolio management
Engagements with management teams to share tailored analytic insights from Logos Analytics to support strategic planning and decision-making.
Risk management and multi-layered underwriting
Proactive risk management approach that integrates scientific, operational, and commercial factors to evaluate intrinsic value and protect investor returns.
Portfolio
Dr. Graham Walmsley serves on the board (NASDAQ: OLMA).
#Biopharma / Therapeutics
Dr. Graham Walmsley serves on the board (NASDAQ: OLMA).
#Biopharma / Therapeutics